IV infusion therapy is the principal modality for administration of anticancer drugs. According to British Journal of nursing (2022), Phlebitis is a serious health problem that affects a large proportion of hospitalized cancer patients receiving intravenous therapy. The average incidence of phlebitis was 61.5%. The main aim of this study is to evaluate the effect of glycerine magnesium sulphate on chemotherapy induced infusion phlebitis among cancer patients in selected hospitals of Gujarat. In the present study pre-experimental (one group pre-test post-test) research design was used. The study was conducted in selected hospitals of Gujarat state. The non-probability purposive sampling technique was used for selecting 30 samples with chemotherapy induced infusion phlebitis. Data were collected with the help of two sections. Section A includes question regarding demographic variables. Section B includes data regarding clinical variables and a modified VIP score. Modified VIP Score was prepared to assess the chemotherapy induced infusion phlebitis.

Objectives

1.       To assess the pre-test level of chemotherapy induced infusion phlebitis among cancer patients in selected hospitals of Gujarat.

2.       To assess the post-test level of chemotherapy induced infusion phlebitis among cancer patients in selected hospitals of Gujarat.

3.       To determine effect of glycerine magnesium sulphate on chemotherapy induced infusion phlebitis among cancer patients in selected hospitals of Gujarat.